. Simply put, I was wrong.
The Warhammer 40K universe is home to plenty of tangling spiderwebs of plot, though to look at Warhammer 40,000: Kill Team, you wouldn’t know it. In fact, from the look of things to an outsider sitting in on a playthrough it would seem as though you’re a space marine sent to clear out an enormous spaceship teeming with Orks by any means necessary. This is peace through superior firepower, and how. With the holiday season carrying in Warhammer 40,000: Space Marine on a wave of other new releases, it’s obvious that Kill Team was tossed together in an effort to hype up the main breadwinner. Obvious how? It channels the isometric Alien Breed: Evolution series and all of the other arcade releases basking in its glow to provide a hollow dual-stick shooter that’s satisfying, but only in short bursts…like machine gun fire.
I’m not usually a big fan of network TV. I’ll stick to series on DVD and Netflix, thank you very much. Of course, that doesn’t mean I don’t channel surf. Occasionally I come across a blatant rip-off of the English-dubbed Most Extreme Elimination Challenge (MxC), a hilarious take on the Japanese game show Takeshi’s Castle. It’s brilliantly rewritten with crude jokes and entertaining commentators, and I can usually count on it for a few laughs. Unfortunately, America decided it needed to create its own similarly-themed equivalent, Wipeout. Only rather than running contestants through different challenges, all if not most of the competitors on Wipeout compete in water-based obstacle courses complete with pithy commentary to accompany their pitfalls and failings.Welcome to this thread which deals with the damage types the Elementalist can deal and how to increase your potential when dealing raw damage, conditions or critical hits. Of course you can't have everything, e.g. focusing on critical hits by using a lot of Air Magic, traits that augment critical hits and upgrades to equipment that add a "+x% bonus to critical damage", will diminish your ability to build up e.g. strong condition damage.
After going through the following tables and texts, I hope you will have understood the basics and can build your own combinations to enjoy your Guild Wars 2 game play.
There are two degenerating conditions available to the Elementalist: Bleeding and Burning:
1. Bleeding
As you can see, there are three components to the damage done by Bleeding. As those are multiplied (damage x stacks x time) you can outweigh the fact e.g that you are only half the level of your opponent by doubling the time of the bleed applied. So adding stack and duration can be more vital than having a great base damage.
Also notice that your "Power" attribute does not contribute to your level as well as your weapon damage.
2. Burning
If you take a closer look at the table for "Burning", you will notice that it lacks the ability to stack. You either burn or you don't. What makes this condition dangerous is the high base damage, as its level depended component is eight times as high as in bleeding. Keeping up the burning even a few seconds does much more damage, so preventing foes to e.g. move out of field effects will increase the damage.
Can I increase my base condition damage?
Yes. We have also incorporated those numbers into the tables listed above, when we gave our Elementalist 5 trait points in Earth Magic. Each point in Earth Magic is worth 10 condition damage. With 20 points in Earth Magic, his base damage would increase from 51 for one stack of Bleeding to 81 (which is almost a 60% increase of damage).
Can you decrease the duration of the burning and bleeding conditions?
No. Guild Wars 2 knows only skills, upgrades and traits that increase the duration of the conditions. To "decrease" the duration you have to remove the condition, e.g. by triggering the utility skill "Cleansing Fire".
What does Might do to condition damage?
The Might boon (
) does increase the condition damage by 5 + 0.375*Level for each stack, so our example Elementalist from the tables listed above would gain 35 condition damage from a single stack of Might.) does increase the condition damage by 5 + 0.375*Level for each stack, so our example Elementalist from the tables listed above would gain 35 condition damage from a single stack of Might.
How does Expertise/Condition Duration change the numbers?
Each point in Fire Magic will increase Expertise by one point, which translates into +1% to the duration of the condition. Lets assume 20 trait points in Fire Magic, the 5 seconds of burning condition would be increased to 6 seconds.
How do modifiers from items change the numbers?
Since Superior runes (e.g. Rune of the Elementalist add a max. of +57 points to condition damage, the upgrade slots on armour might be better spent on other things, when you compare the numbers to a level gain). As a rule of thumb (as numbers come from community calculation and not official Arena.Net numbers), it "plus to condition damage" should be used in blocks of 20, because less has no effect on bleeding.
What are the best trait lines to pick, when you want to concentrate on condition damage?
As you can see from the explanations and examples in the last paragraphs, Fire Magic and Earth Magic will support a build made to deal heavy condition damage.
You can extrapolate this to other professions as well: All trait lines that increase Expertise and Malice will have the same effect on condition builds than Earth & Fire Magic.A study from the Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M.D. Anderson Cancer Center, 1155 Pressler Dr., Houston, TX 77030, USA, and others states that “Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.“ This research paper was published, in the 28 September 2019 issue of the journal “N Engl J Med. (one of the best journals in Clinical Medicine with an impact factor of 70+)“, by Profs. Robert L. Coleman, M.D., Michael A. Bookman, M.D., others.
First, given that: (i) each year nearly 14 million people–more than 2 38,000 patients are diagnosed with ovarian cancer every year worldwide– are diagnosed with cancer globally, and little more than half of them will die due to lack of curative treatment available at present; (ii) cancer deaths globally are expected to be doubled by 2030; and (iii) cancer causes the highest economic loss compared to all the known causes of death worldwide, there is an urgent need to find: (i) a way to prevent an individual from being susceptible to cancer by strengthening his/her own immune system (Cancer immunotherapy); (ii) a cheaper alternative to the existing expensive anticancer drugs; (iii) a side-effect-free natural product-based anticancer drugs that target cancer stem cells; and (iv) a way to effectively treat and prevent metastatic progression and relapse of ovarian cancers.
This study suggests a therapeutic strategy for stalling the progression of p53-deficient/deleted or mutant-p53 expressing advanced metastatic ovarian cancers. By activating tumor suppressor p53’s unmutated “homologous protein such as TAp73/p63” in p53-deficient or mutant-p53 expressing metastatic cancer cells, one can stall their progression.
(ii) Research findings: This study presented here suggests, for the first time, that a pharmacological formulation encompassing Veliparib (ABT-888), by decreasing the expression of its target gene, it may: (i) decrease the expression of a number of oncogenes and DNA repair proteins; (ii) increase the expression of tumor/metastasis suppressor genes, such as TPM1 (Tropomycin 1), & CADM1/2 (Cell adhesion molecule 1/2); (iii) increase the expression of a number of other tumor suppressor genes, including p53/TA-p73/p63, and their target genes, INK4a, p19ARF and others (Figure 1);(iv) decreases the expression of Protein phosphatase 2A (PP2A) and others; (v)activate tumor/metastasis suppressor network; (vi) inhibit immunosuppressive/immune-inhibitory receptors/ molecules; (vii) inhibit the activity and proliferation of cancer stem cells; (viii) inhibit tumor growth; and (ix) promote survival (Figures 1-4). Further, the efficacy of Veliparib (ABT-888) can be increased by treating cancer patients with probiotic Lactobacillus rhamnosus (1.0×103 CFU/ml).
Figure 1. Mechanistic insights into how a pharmacological formulation encompassing Veliparib (ABT-888) and/or Lactobacillus Rhamnosus increases the expression of tumor/metastatic suppressors, such as TPM, CADM1/2, p53, TAp73/p63, INK4a, p19ARF and others, inhibits the expression of immune-inhibitory receptors, increases the expression of PP2A, promotes drug sensitivity to cancer cells that are resistant to the treatment of Paclitaxel/Topotecan/Temozolomide, stops the proliferation of cancer stem cells, and stalls the progression of advanced metastatic cancers.
Figure 2 The fact sheet that reveals the current status of PARP1/2 inhibitor Veliparib (ABT-888).
Figure 3 A pharmacological formulation encompassing Vel